Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Cytiva Sweden AB
AB
Active
Org 5561081919
Björkgatan 30, 753 23
Uppsala
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 1967
2170 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Cytiva Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
11B
22B
33B
44B
24.5B
2020
32.7B
2021
38.2B
2022
30.3B
2023
29.8B
2024
EBITDA
SEK millions
0M
2B
4B
6B
8B
4.5B
2020
6.5B
2021
7.0B
2022
3.3B
2023
5.4B
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
24 493 000
32 690 974
38 219 966
30 292 329
29 828 543
Staff expenses
—
—
—
—
—
EBITDA
4 549 000
6 550 277
6 982 306
3 275 767
5 409 988
Depreciation & amort.
−313 000
−367 588
−390 615
−407 022
−420 193
EBIT
4 236 000
6 182 689
6 591 691
2 868 745
4 989 795
Net financials
11 000
−36 494
−6 686
155 150
47 968
Profit before tax
83 000
−32 159
1 686 972
523 895
81 763
Tax
4 000
10 359
−348 627
−75 319
1 530
Net profit
87 000
−21 800
1 338 345
448 576
83 293
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
14 085 000
14 806 481
21 308 662
16 299 824
15 645 976
Equity
2 927 000
1 905 053
3 243 398
2 691 974
1 775 267
Long-term debt
0
0
0
0
0
Short-term debt
9 186 000
10 729 588
15 593 251
10 904 721
10 979 180
Total debt
9 186 000
10 729 588
15 593 251
10 904 721
10 979 180
Financial ratios
5-year trend
EBITDA margin
18.1%
This company
15.8%
Market median
+15% vs market
2020
2024
Equity ratio
11.3%
This company
38.2%
Market median
-70% vs market
2020
2024
Return on equity
4.7%
This company
18.4%
Market median
-74% vs market
2020
2024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
2020
2024
Asset turnover
1.91×
This company
1.12×
Market median
+71% vs market
2020
2024
Debt / equity
7.81×
This company
0.62×
Market median
-1160% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Cytiva Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
